For: | Zuo DS, Dai J, Bo AH, Fan J, Xiao XY. Significance of expression of heat shock protein90α in human gastric cancer. World J Gastroenterol 2003; 9(11): 2616-2618 [PMID: 14606110 DOI: 10.3748/wjg.v9.i11.2616] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i11/2616.htm |
Number | Citing Articles |
1 |
Mi Kyeong Kim. Analysis of the Correlation between Expressions of HSP90α, HSP90β, and GRP94, and the Clinicopathologic Characteristics in Tissues of Non-Small Cell Lung Cancer Patients. The Korean Journal of Clinical Laboratory Science 2017; 49(4): 460 doi: 10.15324/kjcls.2017.49.4.460
|
2 |
Yelena Y. Janjigian, David P. Kelsen. Genomic Dysregulation in gastric tumors. Journal of Surgical Oncology 2013; 107(3): 237 doi: 10.1002/jso.23263
|
3 |
Ming-Chen Ba, Zheng Ba, Yuan-Feng Gong, Kun-Peng Lin, Yin-Bing Wu, Yi-Nuo Tu. Knockdown of lncRNA ZNRD1-AS1 suppresses gastric cancer cell proliferation and metastasis by targeting the miR-9-5p/HSP90AA1 axis. Aging 2021; 13(13): 17285 doi: 10.18632/aging.203209
|
4 |
Francesco Cappello, Sabrina David, Francesca Rappa, Fabio Bucchieri, Lorenzo Marasà, Tommaso E Bartolotta, Felicia Farina, Giovanni Zummo. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase. BMC Cancer 2005; 5(1) doi: 10.1186/1471-2407-5-139
|
5 |
Olga Greengauz-Roberts, Hubert Stöppler, Sachiyo Nomura, Hirokazu Yamaguchi, James R. Goldenring, Robert H. Podolsky, Jeffrey R. Lee, William S. Dynan. Saturation labeling with cysteine-reactive cyanine fluorescent dyes provides increased sensitivity for protein expression profiling of laser-microdissected clinical specimens. PROTEOMICS 2005; 5(7): 1746 doi: 10.1002/pmic.200401068
|
6 |
Khaldoun Almhanna. Current Challenges in Personalized Cancer Medicine. Advances in Pharmacology 2012; 65: 437 doi: 10.1016/B978-0-12-397927-8.00014-2
|
7 |
Nishi Kothari, Khaldoun Almhanna. Targeted Therapies for Solid Tumors. Current Clinical Pathology 2015; : 103 doi: 10.1007/978-1-4939-2047-1_10
|
8 |
Pan Yanglin, Zhao Lina, Liu Zhiguo, Liu Na, Jin Haifeng, Zhang Guoyun, Liang Jie, Wang Jun, Lin Tao, Sun Li, Qiao Taidong, Wang Jianhong, Fan Daiming. KCNE2, a down-regulated gene identified by in silico analysis, suppressed proliferation of gastric cancer cells. Cancer Letters 2007; 246(1-2): 129 doi: 10.1016/j.canlet.2006.02.010
|
9 |
Xin-qiang Liang, Ke-zhi Li, Zhao Li, Ming-zhi Xie, Yan-ping Tang, Jiang-biao Du, Yi Huang, Ji-lin Li, Bang-li Hu. Diagnostic and prognostic value of plasma heat shock protein 90alpha in gastric cancer. International Immunopharmacology 2021; 90: 107145 doi: 10.1016/j.intimp.2020.107145
|
10 |
Can Li, Jie Zhang, Hao Wu, Lili Li, Caiting Yang, Shushu Song, Peike Peng, Miaomiao Shao, Mingming Zhang, Junjie Zhao, Ran Zhao, Weicheng Wu, Yuanyuan Ruan, Lan Wang, Jianxin Gu. Lectin-like oxidized low-density lipoprotein receptor-1 facilitates metastasis of gastric cancer through driving epithelial-mesenchymal transition and PI3K/Akt/GSK3β activation. Scientific Reports 2017; 7(1) doi: 10.1038/srep45275
|
11 |
Tayebeh Mehdipour, Mohammad R. Tohidkia, Amir Ata Saei, Amir Kazemi, Shirin Khajeh, Ali A. Rahim Rahimi, Sepideh Nikfarjam, Mehrdad Farhadi, Monireh Halimi, Ramin Soleimani, Roman A. Zubarev, Mohammad Nouri. Tailoring subtractive cell biopanning to identify diffuse gastric adenocarcinoma‐associated antigens via human scFv antibodies. Immunology 2020; 159(1): 96 doi: 10.1111/imm.13129
|
12 |
Kakoli Das, Patrick Tan. New Advances on Disease Biomarkers and Molecular Targets in Biomedicine. 2013; : 105 doi: 10.1007/978-1-62703-456-2_7
|
13 |
Wooin Lee, Jignesh H Patel, A Craig Lockhart. Novel targets in esophageal and gastric cancer: beyond antiangiogenesis. Expert Opinion on Investigational Drugs 2009; 18(9): 1351 doi: 10.1517/13543780903179286
|
14 |
Tineke E. Buffart, Beatriz Carvalho, Nicole C.T. Grieken, Wessel N. Wieringen, Marianne Tijssen, Elma Meershoek-Klein Kranenbarg, Henk M.W. Verheul, Heike I. Grabsch, Bauke Ylstra, Cornelis J.H. Velde, Gerrit A. Meijer. Losses of Chromosome 5q and 14q Are Associated with Favorable Clinical Outcome of Patients with Gastric Cancer. The Oncologist 2012; 17(5): 653 doi: 10.1634/theoncologist.2010-0379
|
15 |
Marino Venerito, Michael Selgrad, Peter Malfertheiner. Helicobacter pylori: Gastric Cancer and Extragastric Malignancies – Clinical aspects. Helicobacter 2013; 18(s1): 39 doi: 10.1111/hel.12078
|
16 |
Dana Faingold, Jean-Claude Marshall, Emilia Antecka, Sebastian Di Cesare, Alexandre N. Odashiro, Silvin Bakalian, Bruno F. Fernandes, Miguel N. Burnier. Immune Expression and Inhibition of Heat Shock Protein 90 in Uveal Melanoma. Clinical Cancer Research 2008; 14(3): 847 doi: 10.1158/1078-0432.CCR-07-0926
|
17 |
Takashi Oshima, Munetaka Masuda. Molecular targeted agents for gastric and gastroesophageal junction cancer. Surgery Today 2012; 42(4): 313 doi: 10.1007/s00595-011-0065-9
|
18 |
Yanping Tang, Kezhi Li, Zhengmin Cai, Yuxuan Xie, Xiaoyu Tan, Chenglin Su, Jilin Li. Hsp90α Combined with Afp and Tk1 Improved the Diagnostic Value for Hepatocellular Carcinoma. Biomarkers in Medicine 2020; 14(10): 869 doi: 10.2217/bmm-2019-0484
|
19 |
Eiko Hayashi, Yasuhiro Kuramitsu, Futoshi Okada, Masanori Fujimoto, Xiulian Zhang, Masanobu Kobayashi, Norio Iizuka, Yoshiya Ueyama, Kazuyuki Nakamura. Proteomic profiling for cancer progression: Differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines. PROTEOMICS 2005; 5(4): 1024 doi: 10.1002/pmic.200401132
|
20 |
Kyoung-Min Choi, Sung-Jin Kim, Mi-Jung Ji, Eunjung Kim, Jae-Sung Kim, Hyun‑Mee Park, Jae-Young Kim. Activity-based protein profiling and global proteome analysis reveal MASTL as a potential therapeutic target in gastric cancer. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01783-8
|
21 |
Bin Liu, Daohai Qian. Hsp90α and cell death in cancers: a review. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01021-0
|
22 |
Cemil Yüksel, Salih Burak Gündoğdu, Batuhan Bakırarar, Ayşe Yılmaz Çiftçi, Mesut Tez, Barış Doğu Yıldız. Relationship between HSP90 protein expression
and overall survival and clinicopathological outcomes
in gastric cancer patients. Polish Journal of Surgery 2022; 94(3): 51 doi: 10.5604/01.3001.0015.7551
|
23 |
Zev A. Wainberg, Adrian Anghel, Amy M. Rogers, Amrita J. Desai, Ondrej Kalous, Dylan Conklin, Raul Ayala, Neil A. O'Brien, Cornelia Quadt, Mikhail Akimov, Dennis J. Slamon, Richard S. Finn. Inhibition of HSP90 with AUY922 Induces Synergy in HER2-Amplified Trastuzumab-Resistant Breast and Gastric Cancer. Molecular Cancer Therapeutics 2013; 12(4): 509 doi: 10.1158/1535-7163.MCT-12-0507
|
24 |
Kyung‐Hun Lee, Ju‐Hee Lee, Sae‐Won Han, Seock‐Ah Im, Tae‐You Kim, Do‐Youn Oh, Yung‐Jue Bang. Antitumor activity of NVP‐AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins. Cancer Science 2011; 102(7): 1388 doi: 10.1111/j.1349-7006.2011.01944.x
|
25 |
Oi Wei Mak, Raina Chand, Jóhannes Reynisson, Ivanhoe K. H. Leung. Identification of Isoform-Selective Ligands for the Middle Domain of Heat Shock Protein 90 (Hsp90). International Journal of Molecular Sciences 2019; 20(21): 5333 doi: 10.3390/ijms20215333
|
26 |
Hendrik-Tobias Arkenau. Gastric cancer in the era of molecularly targeted agents: current drug development strategies. Journal of Cancer Research and Clinical Oncology 2009; 135(7): 855 doi: 10.1007/s00432-009-0583-7
|
27 |
Mariana Ferreira Leal, Fernanda Wisnieski, Carolina de Oliveira Gigek, Leonardo Caires do Santos, Danielle Queiroz Calcagno, Rommel Rodriguez Burbano, Marilia Cardoso Smith. What gastric cancer proteomic studies show about gastric carcinogenesis?. Tumor Biology 2016; 37(8): 9991 doi: 10.1007/s13277-016-5043-9
|
28 |
Stephen L. Strobel. Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma. Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas 2005; 4: 531 doi: 10.1016/S1874-5784(05)80115-1
|
29 |
Nadia Boroumand, Hossein Saghi, Amir Avan, Amirhossein Bahreyni, Mikhail Ryzhikov, Majid Khazaei, Seyed Mahdi Hassanian. Therapeutic potency of heat-shock protein-90 pharmacological inhibitors in the treatment of gastrointestinal cancer, current status and perspectives. Journal of Pharmacy and Pharmacology 2018; 70(2): 151 doi: 10.1111/jphp.12824
|